These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 35260755

  • 1. Inhibition of RANKL and Sema4D improves residual ridge resorption in mice.
    Hisamoto M, Kimura S, Iwata K, Iwanaga T, Yokoyama A.
    Sci Rep; 2022 Mar 08; 12(1):4094. PubMed ID: 35260755
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.
    Mediero A, Wilder T, Shah L, Cronstein BN.
    FASEB J; 2018 Jul 08; 32(7):3487-3501. PubMed ID: 29394106
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cumambrin A prevents OVX-induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways.
    Zhou L, Liu Q, Hong G, Song F, Zhao J, Yuan J, Xu J, Tan RX, Tickner J, Gu Q, Xu J.
    FASEB J; 2019 Jun 08; 33(6):6726-6735. PubMed ID: 30807230
    [Abstract] [Full Text] [Related]

  • 6. Suppression of bone formation by osteoclastic expression of semaphorin 4D.
    Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, Friedel RH, Takayanagi H.
    Nat Med; 2011 Oct 23; 17(11):1473-80. PubMed ID: 22019888
    [Abstract] [Full Text] [Related]

  • 7. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
    Chen D, Ye Z, Wang C, Wang Q, Wang H, Kuek V, Wang Z, Qiu H, Yuan J, Kenny J, Yang F, He J, Liu Y, Wang G, Zhang M, Zhang G, Wang J, Chen P, Xu J.
    Pharmacol Res; 2020 Sep 23; 159():104944. PubMed ID: 32454224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anacardic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo.
    Zhao K, Jia Y, Peng J, Pang C, Zhang T, Han W, Jiang J, Lu X, Zhu J, Qian Y.
    FASEB J; 2019 Aug 23; 33(8):9100-9115. PubMed ID: 31050917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zanthoxylum piperitum alleviates the bone loss in osteoporosis via inhibition of RANKL-induced c-fos/NFATc1/NF-κB pathway.
    Kim MH, Lee H, Ha IJ, Yang WM.
    Phytomedicine; 2021 Jan 23; 80():153397. PubMed ID: 33130475
    [Abstract] [Full Text] [Related]

  • 14. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K, Yan Z, Wang Y, Yang Y, Cai M, Huang C, Li B, Yang M, Zhou X, Wei X, Yang C, Chen Z, Zhai X, Li M.
    Biomed Pharmacother; 2020 Jun 23; 126():110067. PubMed ID: 32272431
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.
    Liang S, Nian Z, Shi K.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1028-1035. PubMed ID: 32321638
    [Abstract] [Full Text] [Related]

  • 16. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J, Jing Z, Hu W, Yu J, Cui X.
    Med Sci Monit; 2017 Oct 24; 23():5056-5069. PubMed ID: 29061958
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z, Cheng J, Liu Q, Zhou L, Kenny J, Wang T, Lin X, Yuan J, Quinn JMW, Tickner J, Hong G, Qin A, Zhao J, Xu J.
    Mol Cell Endocrinol; 2017 Jan 05; 439():369-378. PubMed ID: 27664516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.